• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABIOMED EUROPE, GMBH (GERMANY) IMPELLA LP2.5

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABIOMED EUROPE, GMBH (GERMANY) IMPELLA LP2.5 Back to Search Results
Model Number IMPELLA LP2.5
Device Problem Entrapment of Device (1212)
Patient Problem Perforation of Vessels (2135)
Event Date 02/12/2016
Event Type  Injury  
Manufacturer Narrative
The device was not returned for investigation; consequently a device failure evaluation could not be performed.The aic console logs were returned for analysis.The data logs provided information on the pump's performance and the patient's condition during the case.The long time logs showed that there was good patient pressure throughout the case.The normal patient pressures that were recorded for almost 2 days before the surgery make it unlikely that the ventricle was perforated during pump insertion.Cardiac tamponade symptoms can manifest in as little as 30 minutes after perforation of the ventricle wall.No symptoms were noted leading up to the procedure making it unlikely that the ventricle was perforated before the cabg began.In addition, the logs show good flow and there were no suction alarms before the surgery.If a leak was present during support, low volume would cause suction alarms to be triggered.Good flow suggests the ventricle was intact and completely sealed.It is likely that the ventricle was perforated during the surgery.The physician noted that the patient's cardiac tissue was prone to tears.The pump could have perforated the ventricle at two points during cabg.It is possible that when the pump was cross clamped it could have been moved and pushed through the wall, or it could have occurred when the physician manipulated the heart to look for targets.In conclusion, without the ability to evaluate the device in an effort to obtain additional information a definitive root cause for this event could not be determined.It is most likely that the root cause of the perforation was the friable cardiac tissue in the patient combined with manipulation of the heart during bypass with the impella in place.Device was discarded subsequent to use.
 
Event Description
The complainant reported that on (b)(6) 2016 a (b)(6) patient entered the facility's emergency room complaining of shortness of breath and chest pains.The patient was examined and was found to have elevated troponin levels.The patient was taken to the catheterization lab where a diagnostic catheterization was performed that revealed multi-vessel disease and weak left ventricle (lv) function.An impella lp2.5 pump was placed in the patient without issue.The patient brought to the operating room on (b)(6) 2016 for 5 coronary artery bypass grafts (cabg.) the physician performed the procedure using the "cross clamp" technique.When the doctor clamped the aorta and manipulated the heart looking for targets the catheter pigtail was seen be sticking out of the ventricle.The catheter was immediately pulled back and the physician stitched the perforation.With the repair successfully completed the doctor completed the grafts.The clamps were then removed and the impella lp2.5 was repositioned back across the valve.The physician stated that the patient had "friable tissue." when stitching the aorta he found that the tissue was thin and could be torn easily.The clinical team believed that the left ventricle perforated when the heart was manipulated during the cabg procedure or possibly during cross clamping.Following the procedure the patient was returned to the intensive care unit in stable condition.The patient had been successfully supported with the impella lp2.5 for over 67 hours when the impella lp2.5 was removed from the patient.The patient was reported to be "doing very well.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPELLA LP2.5
Type of Device
IMPELLA LP2.5
Manufacturer (Section D)
ABIOMED EUROPE, GMBH (GERMANY)
neuehofer weg 3
aachen, germany 13059 , GM
GM  13059, GM
Manufacturer (Section G)
ABIOMED EUROPE, GMBH (GERMANY)
neuehofer weg 3
aachen, germany 13059 , GM
GM   13059, GM
Manufacturer Contact
william bolt
22 cherry hill drive
danvers, MA 01923
9786461451
MDR Report Key5591533
MDR Text Key43154806
Report Number1220648-2016-00006
Device Sequence Number1
Product Code PBL
UDI-Device Identifier00813502011258
UDI-Public00813502011258
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063723
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/17/2017
Device Model NumberIMPELLA LP2.5
Device Catalogue Number5042
Device Lot Number1217967
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date03/25/2016
Event Location Hospital
Date Report to Manufacturer03/25/2016
Date Manufacturer Received03/25/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/28/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-